Choledochal Cyst
12
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Biliary Dilatation National Special Disease Cohort in China
A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction
Host-Microbe Interactions in Biliary Dilatation
Clinical Features and Prognosis of Asymptomatic Biliary Dilatation
Efficacy and Safety of Surgical Treatment for Type IVa CBD
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
The Application of Digital Intelligent Diagnostic and Therapeutic Technology in Biliary Dilation Diagnosis
Timing of Operation in Children With a Prenatal Diagnosis of Choledochal Cyst
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis
Isolated Vascularized Gastric Tube Biliary Enteric Drainage: A Paediatric Case Series Experience.
Bilioenteric Anastomosis by Magnetic Compressive Technique
Superior Bilioenteric Anastomosis by Magnetic Compressive Technique